Gender differences in the identification and management of dyslipidemia

被引：6

作者：

Trynosky, Kelly J. ^{[1
]}

机构：

[1] Heart Grp, Lancaster, PA USA

来源：

JOURNAL OF CARDIOVASCULAR NURSING | 2006年 / 21卷 / 05期

关键词：

dyslipidemia; gender differences; lipid management;

D O I：

10.1097/00005082-200609000-00003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gender differences in the treatment of heart disease have a significant impact on the outcomes and mortality for women. From screening and detection, through treatment and intervention, women are less likely than men to receive guideline-based care. Risk factor modification, including lipid management, is critical to all levels of prevention. This article discusses gender differences in the detection and management of dyslipidemia. By identifying the suboptimal recognition and treatment of lipid abnormalities in women, healthcare professionals can revise their practice patterns in an effort to improve the outcomes for women with cardiovascular disease.

引用

收藏

页码：342 / 346

页数：5

相关论文

共 23 条

[11]

Linfante A, 2004, CIRCULATION, V110, P664

[12] Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: Benefits versus risks [J].

McKenney, JM .

AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (4A) :60E-66E

[13] Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH) [J].

McPherson, R ;

Angus, C ;

Murray, P ;

Genest, A .

AMERICAN HEART JOURNAL, 2001, 141 (06) :949-956

[14] Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada [J].

Miller, M ;

Byington, R ;

Hunninghake, D ;

Pitt, B ;

Furberg, CD .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (03) :343-347

[15] Guide to preventive cardiology for women [J].

Mosca, L ;

Grundy, SM ;

Judelson, D ;

King, K ;

Limacher, M ;

Oparil, S ;

Pasternak, R ;

Pearson, TA ;

Redberg, RF ;

Smith, SC ;

Winston, M ;

Zinberg, S .

CIRCULATION, 1999, 99 (18) :2480-2484

[16] National study of physician awareness and adherence to cardiovascular disease prevention guidelines [J].

Mosca, L ;

Linfante, AH ;

Benjamin, EJ ;

Berra, K ;

Hayes, SN ;

Walsh, BW ;

Fabunmi, RP ;

Kwan, J ;

Mills, T ;

Simpson, SL .

CIRCULATION, 2005, 111 (04) :499-510

[17] Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting [J].

Mosca, L ;

Merz, NB ;

Blumenthal, RS ;

Cziraky, MJ ;

Fabunmi, RP ;

Sarawate, C ;

Watson, KE ;

Willey, VJ ;

Stanek, EJ .

CIRCULATION, 2005, 111 (04) :488-493

[18] The Lipid Treatment Assessment Project (L-TAP) -: A multicenter survey to evaluate the percentages of dyslipidemic, patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals [J].

Pearson, TA ;

Laurora, I ;

Chu, H ;

Kafonek, S .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :459-467

[19] C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [J].

Ridker, PM ;

Hennekens, CH ;

Buring, JE ;

Rifai, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (12) :836-843

[20] Current overview of statin-induced myopathy [J].

Rosenson, RS .

AMERICAN JOURNAL OF MEDICINE, 2004, 116 (06) :408-416